Feeding induced by cannabinoids is mediated independently of the melanocortin system

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Sinnayah, Puspha ^a   Jobst, Erin E ^a,b   Rathner, Joseph A ^c   Caldera Siu, Angela D ^d   Tonelli Lemos, Luciana ^a   Eusterbrock, Aaron J ^a   Enriori, Pablo J ^a   Pothos, Emmanuel N ^d   Grove, Kevin L ^a   Cowley, Michael A ^a,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PACIFIC UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE; MELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ENERGY METABOLISM; ENZYME ACTIVATION; FEEDING BEHAVIOR; GENOTYPE; HORMONE ACTION; MALE; MOUSE; NERVE CELL NETWORK; NONHUMAN; NUCLEUS ACCUMBENS; REWARD; VENTRAL TEGMENTUM; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECT; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

CANNABIS SATIVA; MUS;

ANIMALS; CANNABINOIDS; FEEDING BEHAVIOR; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MELANOCORTINS; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 48249095521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002202     Document Type: Article

References (55)

1. Molavi B, Rasouli N, Kern PA (2006) The prevention and treatment of metabolic syndrome and high-risk obesity. Curr Opin Cardiol 21: 479-485.
2. Di Matzo V, Goparaju SK, Wang L, Liu J, Batkai S, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
3. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-1397.
4. Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8: 571-578.
5. Kask A, Rago L, Mutulis F, Pahkla R, Wikberg JE, et al. (1998) Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Common 245: 90-93.
6. Skuladouir GV, Jonsson L, Skarphedinsson JO, Mutulis F, Muceniece R, et al. (1999) Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 126: 27-34.
7. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168.
8. Hentges ST, Low MJ, Williams JT (2005) Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25: 9746-9751.
9. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
10. Roitman MF, Stuber GD, Phillips PE, Wightman RM, Carelli RM (2004) Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24: 1265-1271.
11. Cheer JF, Kendall DA, Mason R, Marsden CA (2003) Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44: 633-641.
12. Wu X, French ED (2000) Effects of chronic delta9-tctrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiologic-1 assessment. Neuropharmacology 39: 391-398.
13. Szabo B, Siemes S, Wallmichrath I (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 15: 2057-2061.
14. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, et al. (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116: 3229-3239.
15. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
16. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, et al. (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell MeLab 5: 181-194.
17. Paxinos G, Franklin KBJ (2001) The mouse brain stereotaxic co-ordinates. San Diego, CA: Academic Press.
18. Cota D, Tschop MH, Horvath TL, Levine AS (2006) Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51: 85-107.
19. Mahler SV, Smith KS, Berridge KC (2007) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32: 2267-2278.
20. Solinas M, Yasar S, Goldberg SR (2007) Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res 56: 393-405.
21. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA (2006) Two brain sites for cannabinoid reward. J Neurosci 26: 4901-4907.
22. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, et al. (2006) Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51: 811-822.
23. Ho J, Cox JM, Wagner EJ (2007) Cannabinoid-induced hyperphagia: Correlation with inhibition of proopiomelanocortin neurons? Physiol Behav.
24. Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA (2003) Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) 167: 103-111.
25. Zhou D, Shearman LP (2004) Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav 77: 117-125.
26. Verty AN, McFarlane JR, McGregor IS, Mallet PE (2004) Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology 145: 3224-3231.
27. Pritchard LE, White A (2005) Agouti-related protein: more than a melanocortin-4 receptor antagonist? Peptides 26: 1759-1770.
28. Iverson I (2000) The Science of Marijuana. Oxford: Oxford University Press.
29. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, et al. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CBI) receptors. Psychopharmacology (Berl) 132: 104-106.
30. Simiand J, Keane M, Keane PE, Soubrie P (1998) SR 1417 16, a CBI cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179-181.
31. Phillips AG, Ahn S, Howland JG (2003) Amygdalar control or the mesocorticolimbic dopamine system: parallel pathways to motivated behavior. Neurosci Biobehav Rev 27: 543-554.
32. Gardner EL (2005) Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81: 263-284.
33. Alonso R, Voutsinos B, Fournier M, Labie C, Steinberg R, et al. (1999) Blockade ofcannabinoid receptors by SR 141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced cloparnine D2 function. Neuroscience 91: 607-620.
34. Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS (2001) The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res 921: 240-255.
35. Singh ME, Verty AN, Price I, McGregor IS, Mallet PE (2004) Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology 47: 1157-1169.
36. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, et al. (2001) Immediate and prolonged patterns of Agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142: 1050-1056.
37. Elmquist JK, Elias CF, Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232.
38. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, et al. (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 74: 683-701.
39. Madden CJ, Morrison SF (2004) Excitatory amino acid receptors in the dorsomedial hypothalamus mediate prostaglandin-evoked thermogenesis in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 286: R320-325.
40. Cerri M, Morrison SF (2005) Activation of lateral hypothalamic neurons stimulates brown adipose tissue thermogenesis. Neuroscience 135: 627-638.
41. Jamshidi N, Taylor DA (2001) Anandamide administration into the ventrome-dial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 1151-1154.
42. Stellar E (1954) The physiology of motivation. Psychol Rev 61: 5-22.
43. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23: 7-11.
44. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601.
45. Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, et al. (2007) Cannabinoids excite hypothalamic melanin-concentraing hormone but inhibit hypocretin/orexin neurons:implications for cannabinoid actions on food intake and cognitive aroursal. J Neurosci 27: 4870-4881.
46. Jo YH, Chen YJ, Chua SC Jr, Talmage DA, Role LW (2005) Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48: 1055-1066.
47. Clegg DJ, Air EL, Woods SC, Seeley RJ (2002) Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated. Endocrinology 143: 2995-3000.
48. Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid CBI receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462: 125-132.
49. Hernandez L, Hoebel BG (1988) Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol Behav 44: 599-606.
50. Pothos EN, Creese I, Hoebel BG (1995) Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci 15: 6640-6650.
51. Pothos EN, Hernandez L, Hoebel BG (1995) Chronic food deprivation decreases extracellular dopamine in the nucleus accumbens: implications for a possible neurochemical link between weight loss and drug abuse. Obes Res 3 Suppl 4: 525S-529S.
52. Pothos EN, Sulzer D, Hoebel BG (1998) Plasticity of quantal size in ventral midbrain dopamine neurons: possible implications for the neurochemistry of feeding and reward. Appetite 31: 405
53. Towell A, Willner P, Muscat R (1988) Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain. Psychopharmacology (Berl) 96: 135-141.
54. Cheer JF, Wassum KM, Heren ML, Phillips PE, Wightman RM (2004) Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci 24: 4393-4400.
55. Paladini CA, Robinson S, Morikawa H, Williams JT, Palmiter RD (2003) Dopiamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc Natl Acad Sci U S A 100: 2866-2871.